Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Iron Deficiency Anemia, Pregnancy

In brief

Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.

Key facts

Study ID
NCT05462704
Run by
Women and Infants Hospital of Rhode Island
People needed
300
Starts
2023-01-17
Expected to finish
2027-03-31
Last updated by the study team
2025-06-10

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.